Walleye Trading LLC Seagen Inc. Transaction History

Walleye Trading LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $1.37 Million - $1.62 Million	11,650 New	11,650 $1.5 Million
Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $346,510 - $457,291	2,897 Added 44.62%	9,389 $1.35 Million
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $481,886 - $645,106	3,380 Added 108.61%	6,492 $1 Million
Q3 2021 Nov 15, 2021	BUY	$142.45 - $169.82 $336,751 - $401,454	2,364 Added 316.04%	3,112 $528,000
Q2 2021 Aug 16, 2021	SELL	$135.08 - $161.1 $372,685 - $444,474	-2,759 Reduced 78.67%	748 $118,000
Q1 2021 May 17, 2021	BUY	$137.51 - $190.8 $482,247 - $669,135	3,507 New	3,507 $487,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.